A Clinical Study on the Efficacy and Safety of the Treatment of Hyperplasia of Mammary Glands With Xiaoru Sanjie Capsule

• Status: Unknown status
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate the efficacy and safety of Xiaoru Sanjie capsule in the treatment of cyclomastopathy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Criteria

Inclusion Criteria:

• 18-65 years old female patients with cyclomastopathy who signed a written informed consent.

• The subjects voluntarily entered the clinical observation whom are hospitalized patients or outpatients with good compliance.

• They have specific symptoms, such as distending pain of the breast, stabbing pain, dull pain and radiating pain.

• They have specific physical sign, for example, we can touch block gland, granular, nodular or cord like glands and etc..

• Breast ultrasound or molybdenum target show I-III class by Breast Imaging Reporting and Data System.

Exclusion Criteria:

• Women who are pregnant or lactating, and who has the history of periarthritis of shoulder.

• Excluding breast fibrocellular tumor, breast cancer and other breast diseases.

• Patients with poor self coordination, mentally retarded patients, or have cardiovascular and cerebrovascular disease, severe organic disease, as well as the hematopoietic system disease or mental illness.

• Be judged as over middle degree depression by the Hamilton's depression scale.

• Allergic constitution patients, and people who are allergic to a variety of drugs.

• Any medical history which may interfere with the test results or increase the risk of patients according to the investigators.

• Patients who have received treatment of other diseases, and those treatment methods and targets may have an impact on the indicators of this study.